PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9511724-8 1998 Long-term treatment with either the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) or bryostatin 1 inhibited levels of Dsg1 and Dsg3, but not Dsg2 in NHEKs and HaCaT cells. Tetradecanoylphorbol Acetate 50-86 desmoglein 3 Homo sapiens 138-142 9511724-8 1998 Long-term treatment with either the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) or bryostatin 1 inhibited levels of Dsg1 and Dsg3, but not Dsg2 in NHEKs and HaCaT cells. Tetradecanoylphorbol Acetate 88-91 desmoglein 3 Homo sapiens 138-142 9511724-9 1998 Chronic TPA also decreased Dsg1 and Dsg3 mRNA levels in NHEKs, further supporting a role for PKC activation in the expression of the suprabasal Dsg1 and Dsg3. Tetradecanoylphorbol Acetate 8-11 desmoglein 3 Homo sapiens 36-40 9511724-9 1998 Chronic TPA also decreased Dsg1 and Dsg3 mRNA levels in NHEKs, further supporting a role for PKC activation in the expression of the suprabasal Dsg1 and Dsg3. Tetradecanoylphorbol Acetate 8-11 desmoglein 3 Homo sapiens 153-157